We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
+13.94%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$518M
AUM Growth
+$159M
Cap. Flow
+$131M
Cap. Flow %
25.19%
Top 10 Hldgs %
65.06%
Holding
140
New
98
Increased
11
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
NCDL icon
Nuveen Churchill Direct Lending
NCDL
+$70.6M
2
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$22.3M
3
CNDT icon
Conduent
CNDT
+$12.3M
4
HLLY icon
Holley
HLLY
+$8.52M
5
GAQ
Generation Asia I Acquisition Limited Class A Ordinary Shares
GAQ
+$5.23M

Top Sells

Rank Stock Value
1
TOST icon
Toast
TOST
+$8.31M
2
VKTX icon
Viking Therapeutics
VKTX
+$5.57M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
+$5.35M
4
TRML
Tourmaline Bio
TRML
+$3.09M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$3.08M

Sector Composition

Rank Sector Weight
1 Healthcare 53.22%
2 Financials 20.04%
3 Technology 17.47%
4 Consumer Discretionary 1.45%
5 Industrials 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PIIIW icon
126
P3 Health Partners Inc Warrant
PIIIW
$207K
$250 ﹤0.01%
+8,333
New +$351
ARQQW icon
127
Arqit Quantum Warrants
ARQQW
$106K
$113 ﹤0.01%
+1,250
New +$107
RGTIW icon
128
Rigetti Computing Warrants
RGTIW
$174M
$113 ﹤0.01%
+1,250
New +$160
ZCAR
129
DELISTED
Zoomcar
ZCAR
– –
0
– –
LMND.WS
130
DELISTED
Lemonade Inc Warrants
LMND.WS
$10 ﹤0.01%
+333
New +$14
SONDW
131
DELISTED
Sonder Holdings Inc Warrants
SONDW
$10 ﹤0.01%
+1,000
New +$13
NSTB.WS
132
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$10 ﹤0.01%
+1,000
New +$10
ALUR.WS
133
DELISTED
Allurion Technologies Warrants
ALUR.WS
$6 ﹤0.01%
+153
New +$16
ACHR icon
134
Archer Aviation
ACHR
$4.78B
$0 ﹤0.01%
+26,282
New +$100K
CELC icon
135
Celcuity
CELC
$4.43B
– –
-65,000
Closed -$1.06M
KPLT icon
136
Katapult Holdings
KPLT
$31.6M
$0 ﹤0.01%
+4,465
New +$65.3K
TOST icon
137
Toast
TOST
$20.6B
– –
-322,578
Closed -$8.31M
VKTX icon
138
Viking Therapeutics
VKTX
$4.02B
– –
-95,000
Closed -$5.57M
BSLKW
139
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$0 ﹤0.01%
+166,666
New +$16.2K
PLMJU
140
DELISTED
Plum Acquisition Corp. III Unit
PLMJU
$0 ﹤0.01%
15,000
-55,000
-79% -$597K
2 3 4 5
6

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return
HPC
Highland Peak Capital Old Greenwich, Connecticut $373M AUM 80.02% 1-Year Est. Return

Blue Owl Capital Holdings's Q3 2024 Portfolio in Review

As of Q3 2024, Blue Owl Capital Holdings held 140 positions worth $518M, up 44% from $360M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Blue Owl Capital Holdings deployed $131M of net new capital in Q3 2024, opening 98 new positions and adding to 11 existing holdings. Its largest new stake was Nuveen Churchill Direct Lending: 4,039,553 shares worth $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 72% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Ultragenyx Pharmaceutical, an estimated $5.35M trimmed.

  • Blue Owl Capital Holdings's largest Q3 2024 buy was Nuveen Churchill Direct Lending: 4,039,553 shares worth $70.4M.
  • Blue Owl Capital Holdings added most to enGene Therapeutics in Q3 2024, an estimated $4.53M increase.
  • Blue Owl Capital Holdings's biggest Q3 2024 reduction was Ultragenyx Pharmaceutical, cutting an estimated $5.35M.
  • Blue Owl Capital Holdings fully exited Toast in Q3 2024, selling an estimated $8.31M.
  • Blue Owl Capital Holdings's ten largest holdings make up 65% of its $518M portfolio in Q3 2024.
  • Blue Owl Capital Holdings opened 98 new positions and closed 3 in Q3 2024.
  • Blue Owl Capital Holdings's portfolio value rose 44% quarter-over-quarter to $518M.

Based on Blue Owl Capital Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.